Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Ending Cash Position : ¥491 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co Ending Cash Position?

Chengdu Easton Biopharmaceuticals Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥491 Mil.

Chengdu Easton Biopharmaceuticals Co's quarterly Ending Cash Position increased from Sep. 2024 (¥582 Mil) to Dec. 2024 (¥965 Mil) but then declined from Dec. 2024 (¥965 Mil) to Mar. 2025 (¥491 Mil).

Chengdu Easton Biopharmaceuticals Co's annual Ending Cash Position declined from Dec. 2022 (¥822 Mil) to Dec. 2023 (¥768 Mil) but then increased from Dec. 2023 (¥768 Mil) to Dec. 2024 (¥965 Mil).

Chengdu Easton Biopharmaceuticals Co Ending Cash Position Historical Data

The historical data trend for Chengdu Easton Biopharmaceuticals Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Easton Biopharmaceuticals Co Ending Cash Position Chart

Chengdu Easton Biopharmaceuticals Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

1,055.29

1,035.90

821.86

767.54

965.18

Chengdu Easton Biopharmaceuticals Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															816.63	662.59	582.25	965.18	491.00

Chengdu Easton Biopharmaceuticals Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Chengdu Easton Biopharmaceuticals Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	767.541	+	197.638
	=	965

Chengdu Easton Biopharmaceuticals Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	965.179	+	-474.183
	=	491

Chengdu Easton Biopharmaceuticals Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Easton Biopharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731

Website

http://www.eastonpharma.cn

Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co Headlines

No Headlines